Rothschild & Co Asset Management US’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$103M Buy
2,225,689
+1,001,388
+82% +$43.4M 1.57% 17
2022
Q3
$47.4M Buy
1,224,301
+30,858
+3% +$1.24M 0.81% 48
2022
Q2
$44.5M Buy
1,193,443
+1,064,561
+826% +$43.3M 0.68% 51
2022
Q1
$5.71M Buy
128,882
+4,092
+3% +$177K 0.07% 190
2021
Q4
$5.3M Sell
124,790
-6,706
-5% -$282K 0.06% 213
2021
Q3
$5.71M Buy
131,496
+16,838
+15% +$745K 0.07% 209
2021
Q2
$4.9M Sell
114,658
-10,251
-8% -$431K 0.06% 221
2021
Q1
$4.83M Buy
124,909
+257
+0.2% +$9.73K 0.06% 225
2020
Q4
$4.48M Sell
124,652
-7,319
-6% -$264K 0.06% 234
2020
Q3
$5.04M Sell
131,971
-215,183
-62% -$8.29M 0.09% 238
2020
Q2
$12.2M Buy
+347,154
New +$12.5M 0.18% 196
2017
Q3
Sell
-15,053
Closed -$417K 367
2017
Q2
$417K Sell
15,053
-530
-3% -$14.1K ﹤0.01% 555
2017
Q1
$388K Sell
15,583
-5,622
-27% -$137K ﹤0.01% 562
2016
Q4
$459K Buy
21,205
+3,106
+17% +$67.8K 0.01% 533
2016
Q3
$431K Buy
+18,099
New +$432K 0.01% 499

Other funds holding BSX

Rothschild & Co Asset Management US's BSX Position: Q4 2022 in Review

Rothschild & Co Asset Management US increased its Boston Scientific (BSX) stake by 82% in Q4 2022, buying an estimated $43.4M and bringing the position to 2,225,689 shares worth $103M. The position accounts for 1.57% of the portfolio, ranked #17.

Rothschild & Co Asset Management US first reported a position in BSX in Q3 2016 and has held it in 15 quarters since. 929 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Rothschild & Co Asset Management US held 2,225,689 shares of Boston Scientific worth $103M as of Q4 2022.
  • Rothschild & Co Asset Management US bought 1,001,388 Boston Scientific shares in Q4 2022, an estimated $43.4M.
  • Boston Scientific made up 1.57% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #17 holding.
  • Rothschild & Co Asset Management US first reported a position in Boston Scientific in Q3 2016 and has held it in 15 quarters since.
  • 929 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.